Cardioplexol, Kardioplege Lösung

7680680150016 CH-68015 Lösung
Cardioplexol, Kardioplege Lösung
Cardioplexol, Kardioplege Lösung
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Set
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
25/03/2026
Summary of Product Characteristics
Français
25/03/2026
Summary of Product Characteristics
Italien
25/03/2026

Detailed composition

Substance Quantity Type Category
procaini hydrochloridum
0.3 G Substance Wirkstoff (Principe actif)
magnesii sulfas heptahydricus
4.0 G Substance Wirkstoff (Principe actif)
magnesii sulfas heptahydricus
4.0 G Substance Wirkstoff (Principe actif)
kalii chloridum
0.746 G Substance Wirkstoff (Principe actif)
kalii chloridum
0.746 G Substance Wirkstoff (Principe actif)
acidum hydrochloridum
- Substance HNIDK
xylitolum
4.5 G Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
xylitolum
4.5 G Substance Wirkstoff (Principe actif)
procaini hydrochloridum
0.3 G Substance Wirkstoff (Principe actif)
acidum citricum monohydricum
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
- Substance HBESI
procaini hydrochloridum
1.1 MMOL Substance WIZUS
natrium
345.0 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
procaini hydrochloridum
1.1 MMOL Substance Wirkstoff (Principe actif)
magnesii sulfas heptahydricus
16.2 MMOL Substance Wirkstoff (Principe actif)
kalii chloridum
10.0 MMOL Substance Wirkstoff (Principe actif)
xylitolum
29.6 MMOL Substance Wirkstoff (Principe actif)

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
68015
Drug name
Cardioplexol, Kardioplege Lösung
Galenic form
LSKP
ATC Code
B05XA16
Authorization status
Z
Dispensing category
B
First authorization
31/08/2023
Authorization expiration date
30/08/2028
IT Number
02.99.0.
Domain
Human medicine
Field of application
Kardioplegie-Lösung bei Herzoperationen

Package details

Description (FR)
CARDIOPLEXOL 4/0.746/4.5/0.3 g sol 1 pce
Description (DE)
CARDIOPLEXOL 4/0.746/4.5/0.3 g Lös. 1 Stk
Market launch
31/08/2023
Narcotic (BTM)
No
Buy us a coffee Explore the data